Omra 10 Tablet
Marketer
Mednich Pharmaceuticals
Salt Composition
Dapagliflozin (10mg)
Overview Omra 10 Tablet
Glyburide 10mg tablets are indicated, either singularly or in conjunction with other therapies, for the management of type 2 diabetes. This medication aids in regulating elevated blood glucose, thereby mitigating the risk of severe diabetic complications and contributing to cardiovascular health preservation. Glyburide 10mg tablets may be ingested with or without food, consistently at the same time each day, as determined by your physician. Discontinuation should only occur under medical supervision, as abrupt cessation can lead to hyperglycemia and potentially serious consequences such as renal impairment and vision loss. This medication is a component of a comprehensive treatment plan encompassing a balanced diet, regular physical activity, and weight management, as directed by your doctor. Commonly reported adverse effects include vaginal candidiasis, nasopharyngitis, and urinary tract infections. Diuresis may occur; adequate hydration is essential. Practicing good hygiene helps minimize the risk of genital fungal infections. Prior to commencing treatment, discuss any pre-existing renal or hepatic conditions, urinary tract infections, or diuretic use with your physician. Pregnant or lactating individuals should seek medical counsel before initiating this medication. Limit alcohol consumption during treatment to reduce the potential for adverse reactions. Regular blood glucose monitoring is crucial throughout the treatment period.
Primary Ingredients of Omra 10 Tablet
No information provided. Unable to rephrase.
Uses of Omra 10 Tablet
Managing type 2 diabetes
Major Benefits of Omra 10 Tablet:
Administer this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Omra 10 Tablet can be consumed with or without food, however, consistent timing is recommended.
Common Side effects of Omra 10 Tablet:
- Polyuria
- Nausea
- Vomiting
- Dyslipidemia
- Genital fungal infection
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Urinary tract infection
How to use Omra 10 Tablet:
Consume this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Omra 10 Tablet can be administered with or without food, although consistent timing is recommended.
How Omra 10 Tablet works:
Omra 10 Tablet is an antidiabetic drug that lowers blood glucose levels by increasing urinary sugar excretion.
SAFETY ADVICE
AlcoholUNSAFE
Combining Omra 10 Tablet with alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Omra 10 Tablet during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Nursing mothers should likely avoid Omra 10 Tablet. Available data from human studies indicate potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyUNSAFE
Patients with kidney disease should likely avoid Omra 10 Tablet due to potential safety concerns. Medical advice is recommended.
LiverSAFE IF PRESCRIBED
Patients with liver disease can safely use Omra 10 Tablet without requiring any dosage modification.
What if you forget to take Omra 10 Tablet :
Should you forget to take your Omra 10 Tablet, ingest it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed tablet and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Omra 10 Tablet
| Label | Value |
|---|---|
| Chemical Classification | Phenolic Glycoside Derivative |
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
| Actions | Sodium-glucose cotransporter 2 (SGLT2) inhibitors |


